Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
34
RLMD Quote, Financials, Valuation and Earnings
Last price:
$3.79
Seasonality move
:
-2.79%
Day range:
$3.77 - $4.06
52-week range:
$0.24 - $5.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
29.75x
Volume:
414K
Avg. volume:
858.1K
1-year change:
859.76%
Market cap:
$281.6M
Revenue:
--
EPS (TTM):
-$1.80
Earnings Data
Next earnings date for RLMD
Mar 26
2026
Most recent earnings per share
-$0.30
Missed by $0.30
(Nov 13/2025)
Consensus Estimate
--
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RLMD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 | -- | -- | -- | -- | -- |
| 11/13/2025 | Q3 | -- | -- | -$0.30 | -- | -- |
| 08/07/2025 | Q2 | -- | -- | -$0.30 | -- | -- |
| 05/12/2025 | Q1 | -- | -- | -$0.58 | -- | -- |
| 03/27/2025 | Q4 | -- | -- | -$0.62 | -- | -- |
| 11/07/2024 | Q3 | -- | -- | -$0.72 | -- | -- |
| 08/07/2024 | Q2 | -- | -- | -$0.59 | -- | -- |
| 05/08/2024 | Q1 | -- | -- | -$0.72 | -- | -- |
| 03/19/2024 | Q4 | -- | -- | -$0.83 | -- | -- |
| 11/08/2023 | Q3 | -- | -- | -$0.73 | -- | -- |
| 08/08/2023 | Q2 | -- | -- | -$0.84 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.87 | -- | -- |
| 03/23/2023 | Q4 | -- | -- | -$1.26 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$1.31 | -$1.47 | $0.16 |
| 08/11/2022 | Q2 | -- | -- | -$1.33 | -$1.32 | -$0.01 |
| 05/05/2022 | Q1 | -- | -- | -$1.40 | -$1.22 | -$0.18 |
| 03/23/2022 | Q4 | -- | -- | -$1.80 | -$1.88 | $0.08 |
| 11/11/2021 | Q3 | -- | -- | -$2.44 | -$1.55 | -$0.89 |
| 08/10/2021 | Q2 | -- | -- | -$1.56 | -$1.47 | -$0.09 |
| 05/12/2021 | Q1 | -- | -- | -$1.34 | -$1.42 | $0.08 |
| 03/23/2021 | Q4 | -- | -- | -$1.29 | -$1.31 | $0.01 |
| 11/12/2020 | Q3 | -- | -- | -$1.05 | -$0.94 | -$0.11 |
| 08/12/2020 | Q2 | -- | -- | -$0.73 | -$0.63 | -$0.11 |
| 05/15/2020 | Q1 | -- | -- | -$0.72 | -$0.37 | -$0.35 |
| 12/31/2019 | Q4 | -- | -- | -$0.39 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.38 | -- | -- |
Relmada Therapeutics, Inc. Earnings Questions
-
How Much did Relmada Therapeutics, Inc. Generate in Revenue Last Quarter?
Relmada Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Relmada Therapeutics, Inc. Beat Earnings Last Quarter?
Relmada Therapeutics, Inc. announced earnings per share of -$0.30 which represents a miss of analyst forecast a -- per share.
-
Is Relmada Therapeutics, Inc. Profitable?
Relmada Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Relmada Therapeutics, Inc. EPS Next Year?
Relmada Therapeutics, Inc.'s earnings are forecast to decrease from -$2.65 per share to -$0.83 per share next year representing a decrease of -68.7%.
-
When is Relmada Therapeutics, Inc.'s Earnings Date?
Relmada Therapeutics, Inc.'s next earnings date is March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 18.69% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.31% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 3.48% over the past day.
